Portfolio Management with Devin Redmond

Portfolio Management with Devin Redmond

Up next

Impact Of The Trade War

There has been a lot of discussion over the past few days about tariffs and the trade relationship between Canada and the United States. The events of Friday where Canada withdrew from the negotiations put the impasse in stark terms. Most of that discussion has focused on manufac ...  Show more

Grocery Anchored Shopping with John McNellis

John McNellis is based in Palo Alto and has been in commercial real estate for more than 40 years. He has been focused on grocery anchored shopping centers in Northern California for most of that time. On today's show we are talking about what is working today and the fundamental ...  Show more

Recommended Episodes

Smart Money ≠ High Returns
Motley Fool Hidden Gems Investing

A red hot software company is continuing to impress investors. (00:21) Ricky Mulvey and David Meier offer up some counter programming for election night. They discuss: - Palantir’s impressive results. - Harvard’s “just ok” endowment returns. - Why individuals have advantages over ...  Show more

Redfin On The Attack
Motley Fool Hidden Gems Investing

Real estate is always a tough business to be in, but especially right now.  Redfin is trying to meet customers on multiple fronts from studio apartment rentals to selling $5 million homes.  Glenn Kelman has been CEO of Redfin since 2005 guiding the real estate technology compan ...  Show more

Building My Own Accounting Software with Ben Taylor
The Finance & Accounting Show

One of the challenges that a lot of small businesses have---> Find a solid system to help them effectively manage their inventory. The truth is most accounting software just isn't great at it. However, there is a new option that business owners love, so we sat down with the found ...  Show more

Leading with science: A deep dive on biotech
Center For Investment Excellence

In this episode, David Lebovitz, Global Strategist, Multi-Asset Solutions, is joined by Stephen Squinto, Chief Investment Officer, J.P. Morgan Life Sciences Private Capital, to discuss the alternative investment landscape, the private biotech market and areas of opportunity in 20 ...  Show more